Detail akcie NuGen Medical Dv Rg online

Business Summary: NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, NuGen Medical Devices Inc revenues decreased 71% to C$174K. Net loss decreased 54% to C$2.6M. Revenues reflect Asia segment decrease of 83% to C$94K, Others segment decrease from C$1K to C$0K. Lower net loss reflects Medical Equipment, Supplies & Distribution segment loss decrease of 29% to C$3M. Basic Earnings per Share excluding Extraordinary Items increased from -C$0.03 to -C$0.01.